Cleared Abbreviated

K110438 - SENSILASE PAD-IQ

K110438 is an FDA 510(k) clearance for SENSILASE PAD-IQ, manufactured by Vasamed, Inc.. The device is a Class 2 Cardiovascular device with product code DPW cleared through the Abbreviated 510(k) pathway after a 78-day FDA review.

K110438 · Vasamed, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
78d
Days
Class 2
Risk

K110438 is an FDA 510(k) clearance for the SENSILASE PAD-IQ. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Vasamed, Inc. (Stoughton, US). The FDA issued a Cleared decision on May 4, 2011 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Vasamed, Inc. devices

FDA 510(k) Submission Details - K110438

510(k) Number K110438 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 2011
Decision Date May 04, 2011
Days to Decision 78 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 125d · This submission: 78d
Pathway characteristics
Standards-based clearance path.

DPW Device Classification - Class 2, Special Controls

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 78
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K110438.
SONOTT FLOWLAB(R)
K111730 · Em-Tec GmbH · Jan 2012
AUREFLO MONITORING SYSTEM
K112657 · Transonic Systems, Inc. · Dec 2011
DELTEX MEDICAL CARDIOQ EDM
K111542 · Deltex Medical Limited · Oct 2011
DOPPLER MONITOR
K110347 · Cook Vascular, Inc. · Mar 2011
CRITIVIEW
K051145 · Critisense , Ltd. · Jan 2006
VCS DOPPLER TRANSCEIVER, MODEL 09-0023-01
K052209 · Vascular Control Systems, Inc. · Sep 2005